Benign Conditions

New products and services from Accuray, Cook Medical, OPKO Health, Intuitive Surgical, Skipta, Mauna Kea Technologies, and the National Comprehensive Cancer Network.

This list of U.S.-based National Institutes of Health trials is derived from the NIH’s database and includes phase I-IV hypogonadism and BPH trials that are currently recruiting participants.

The American Society of Cataract and Refractive Surgery and the American Academy of Ophthalmology have jointly issued an educational update about cataract surgery complications associated with systemic alpha-blockers based on the recent publication of two studies.

Intravesical administration of a liquid liposomal formulation of onabotulinumtoxinA (“Liposomal BoNT-A,” Lipella Pharmaceuticals) shows promise as a safe and effective treatment for refractory overactive bladder (OAB), according to a pilot study presented at the European Association of Urology annual congress in Stockholm, Sweden.

This guide features products and services from manufacturers that are exhibiting at the AUA annual meeting in Orlando. Exhibit hall booth numbers have been included so that you can search for product demonstrations and exhibits that are of particular interest to you.

Laser photoselective vaporization prostatectomy is permitting surgical intervention for BPH in a widening array of patients, many of whom harbor comorbidities that would ordinarily exclude them from invasive procedures, according to a new multinational report.

A collaborative effort involving Duke University experts in urology, engineering, pathology, and mathematics has resulted in improved efficiency for shock wave lithotripsy, the researchers report.

The Centers for Medicare & Medicaid Services has issued two new codes that describe the UroLift implant procedure for the treatment of enlarged prostate in the April 2014 Update of the Hospital Outpatient Prospective Payment System (OPPS).

In the lawsuit, the urologist contended the circumcision was properly performed and the patient’s curvature was due to a previously asymptomatic Peyronie’s condition, which was exacerbated after the circumcision procedure.

For women undergoing surgery for vaginal prolapse and stress urinary incontinence, neither sacrospinous ligament fixation nor uterosacral ligament vaginal vault suspension was superior to the other for functional or adverse event outcomes, according to a recent study.

A diet typically used to lower blood pressure may reduce the risk of kidney stone development, according to a small, recently published study.

Drugs and devices in the pipeline from Medivation, Astellas Pharma, Teva Pharmaceuticals, Boston Scientific, Northwest Biotherapeutics, and Generex Biotechnology.

New products and services from UroGPO, Caldera Medical, Auxilium Pharmaceuticals, VIVUS, and Jeffrey Albaugh, PhD, APRN.

Insurance coverage has expanded for an epigenetic test for prostate cancer and percutaneous tibial nerve stimulation (PTNS) for the treatment of overactive bladder (OAB).

The latest products and services from Lambert Academic Publishing, the AUA, United Guardian, and SpryPublishing.

Ureteric calculi at a skin-to-stone distance (SSD) of over 13 cm can be successfully managed using extracorporeal shock wave lithotripsy, British researchers report.

Postmenopausal women may reduce their risk of incident kidney stone disease by engaging in even mild physical activity and avoiding excessive caloric intake, analyses of data collected in the Women’s Health Initiative (WHI) Observational Study show.

Older men with at least two lower urinary tract symptoms are more likely to have recently thought about committing suicide, researchers say.

Two separate studies provide insight into a pair of factors-diabetes and changes in the American diet-that may boost the risk of kidney stone formation, including the formation of certain stone subtypes. A third study, meanwhile, suggests that medical professionals who work in operating rooms face a higher risk of stones, possibly because of high stress and low fluid intake.

The FDA has granted 510(k) clearance for American Medical Systems, Inc.’s RetroArc retropubic sling system for treatment of female stress urinary incontinence.

Ceftolozane/tazobactam, an investigational antibiotic, showed positive top-line results in a pivotal phase III clinical trial of the drug’s use in complicated urinary tract infections, Cubist Pharmaceuticals, Inc. reported.

The latest products and services from Mission Pharmacal, Eli Lilly, Richard Wolf Medical Instruments Corp., and Inspire on Purpose Publishing.

The use of voided midstream urine cultures in diagnosing cystitis has limited value but can be modified to avoid undertreatment and inappropriate treatment, according to a recently published study.

An investigational minimally invasive device was found safe and effective in limiting rapid pressure changes within the bladder to reduce symptoms of stress urinary incontinence, the authors of a recently published trial reported.

The FDA has approved a product label addition for the phosphodiesterase-type-5 inhibitor tadalafil (Cialis) that involves its use with finasteride (Proscar).